SCHEMBL1687674

SCHEMBL1687674

CNC(=N)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7951226 0.81 CA2 (0.30)
SCHEMBL3074860 0.72
SCHEMBL8195640 0.70
SCHEMBL14595656 0.68
SCHEMBL13771430 0.67
SCHEMBL17826854 0.67
SCHEMBL3077677 0.65
Hydrochloric Acid SCHEMBL27769840 0.65 LMNA (0.38)
SCHEMBL3078435 0.65
Hydrochloric Acid SCHEMBL28544682 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-221868579-U Multistage grinding device is used in production of O-methyl-N-methyl isourea 山西裕英永旭新材料有限责任公司 2024-10-22 CN claimed
CN-221868579-U Multistage grinding device is used in production of O-methyl-N-methyl isourea 山西裕英永旭新材料有限责任公司 2024-10-22 CN disclosed
CN-221868579-U Multistage grinding device is used in production of O-methyl-N-methyl isourea 山西裕英永旭新材料有限责任公司 2024-10-22 CN disclosed
CN-221868579-U Multistage grinding device is used in production of O-methyl-N-methyl isourea 山西裕英永旭新材料有限责任公司 2024-10-22 CN disclosed
US-20230203086-A1 RIBONUCLEIC ACID PURIFICATION ARES CAPITAL CORPORATION, AS AGENT 2023-06-29 US disclosed
US-20170328909-A1 APTAMERS AND DIAGNOSTIC METHODS FOR DETECTING THE EGF RECEPTOR QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) 2017-11-16 US disclosed
US-20170260531-A1 Aptamers to PDGF and VEGF and Their Use in Treating PDGF and VEGF Mediated Conditions SOMALOGIC OPERATING CO. INC. 2017-09-14 US disclosed
US-20170247702-A1 PDGF and VEGF Aptamers Having Improved Stability and Their Use in Treating PDGF and VEGF Mediated Diseases and Disorders SOMALOGIC OPERATING CO. INC. 2017-08-31 US disclosed
US-9701967-B2 Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions SOMALOGIC, INC. (US) 2017-07-11 US disclosed
US-9695424-B2 PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disorders SOMALOGIC, INC. (US) 2017-07-04 US disclosed
EP-1391454-A1 Substituted benzamide compounds with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2004-02-25 EP disclosed
EP-1195372-A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2002-04-10 EP disclosed
US-6156766-A Benzamide compounds and pharmaceutical use thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2000-12-05 US disclosed
EP-0641781-B1 4-AMINO(ALKYL)CYCLOHEXANE-1-CARBOXAMIDE COMPOUND AND USE THEREOF YOSHITOMI PHARMACEUTICAL (JP) 2000-07-26 EP disclosed
US-5958944-A TREATMENT OF CIRCULATORY DISEASES IN CORONARY, CEREBRAL, RENAL AND PERIPHERAL ARTERIES, AS A THERAPEUTIC AGENT FOR HYPERTENSION, ANGINA PECTORIS, AND RENAL AND PERIPHERAL CIRCULATION DISORDER, ANTIASTHMATIC AGENT YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1999-09-28 US disclosed
EP-0757038-A1 BENZAMIDE COMPOUND AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1997-02-05 EP disclosed
US-5478838-A Treating hypertension, angina pectoris, asthma, improving peripheral circulation YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1995-12-26 US disclosed
EP-0641781-A1 4-AMINO(ALKYL)CYCLOHEXANE-1-CARBOXAMIDE COMPOUND AND USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1995-03-08 EP disclosed
US-4110445-A METHOD FOR ANTAGONIZING ALDOSTERONIC ACTION AND INDUCING DIURESIS BY ADMINISTERING A TETRASUBSTITUTED IMIDAZOLIDINE AMERICAN CYANAMID COMPANY (US) 1978-08-29 US disclosed
US-4044021-A Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism AMERICAN CYANAMID COMPANY (US) 1977-08-23 US disclosed